Statistics for CureVac NV (id:6438 CVAC)
Valuation metrics
Market cap
643.85M
Enterprise value
529.80M
Trailing P/E (ttm)
5.86
Forward P/E
-6.52
PEG ratio
-6.52
Price/Sales (ttm)
9.78
Price/Book (mrq)
1.71
Enterprise Value/Revenue
7.70
Enterprise Value/EBITDA
-1.88
Overview
Shares outstanding
224.34M
Float
123.54M
Shares short
4.21M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
539.83K
Average volume (90 days)
Price summary
52-Week low
2.22
52-Week high
5.28
52-Week change
-41.81%
Beta
2.61
50-Day moving average
2.84
200-Day moving average
3.15
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-131.34%
Operating margin
-493.58%
Operational effectiveness
Return on assets
-24.52%
Return on equity
-54.30%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
28.96
Gross profit (ttm)
-70,608,000.00
EBITDA
-282,376,831.00
Net income to common (ttm)
-290,824,885.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
2.90K%
Balance sheet
Total cash (mrq)
211.53M
Total cash per share (mrq)
3.00
Total debt (mrq)
40.77M
Total Debt/Equity (mrq)
10.37
Current ratio (mrq)
228.70%
Book value per share (mrq)
1.68
Cash flow
Cash flow statement
-302,755,341.00
Levered free cash flow (LFCF)
-231,986,189.00